Viewing StudyNCT00035308

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00035308
Status: COMPLETED
Last Update Posted: 2006-09-25
First Post: 2002-05-02
Brief Title: Safety and Efficacy Study of LJP 394 Abetimus Sodium to Treat Lupus Kidney Disease
Sponsor: La Jolla Pharmaceutical Company
Organization: La Jolla Pharmaceutical Company
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Lupus Glomerulonephritis
Immunologic Diseases
Autoimmune Diseases
Systemic Lupus Erythematosus
Lupus Nephritis
Keywords:
Name View
Lupus Glomerulonephritis View
Immunologic Diseases View
Autoimmune Diseases View
Systemic Lupus Erythematosus View
SLE View
Lupus Nephritis View